Please login to the form below

Not currently logged in
Email:
Password:

Tonix names chief medical officer

Gregory Sullivan is experience academic in psychiatry

The clinical-stage specialty pharma company Tonix Pharmaceuticals has named Dr Gregory Sullivan as its first chief medical officer.

Dr Sullivan, an experienced psychiatrist and researcher, will oversee medical aspects of the New York headquartered company's clinical research and development programme, which is focused on developing treatments for diseases of the central nervous system.

It is the second senior clinical appointment that Tonix has made this year following the hire of Dr Donald Kellerman as senior VP, clinical development and regulatory affairs.

Tonix is bulking up its research team as it anticipates the first trial involving lead candidate TNX-102 SL in fibromyalgia. The drug is also in a more advanced stage of research for post-traumatic stress disorder (PTSD).

Dr Sullivan has enjoyed an extensive clinical career including experience as an assistant Professor of Psychiatry in the Department of Psychiatry at Columbia University Medical Center, a research scientist at the New York State Psychiatric Institute (NYSPI), and as a practicing psychiatrist.

His expertise includes PTSD and has been involved in several studies into the condition. He has also served on the scientific advisory board at Tonix since 2010.

"It is my hope that my medical expertise and scientific background will contribute to the successful development of this promising pipeline of novel therapeutic candidates to bring much needed treatment options to patients suffering with these challenging conditions,” said Dr Sullivan.

4th June 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics